World Hepatitis Day 2026—Let's break it down

Image

FISPGHAN Campaign for World Hepatitis Day
(July 28, 2026)

Image

FISPGHAN Social Media Toolkit
World Hepatitis Day
(July 28, 2025)

This toolkit provides sample social media posts for use by FISPGHAN member societies. All posts are editable and may be translated or customized to reflect local messaging. Use the campaign hashtags:  #WorldHepatitisDay
#HepatitisLetsBreakItDown
#FISPGHAN
#ViralHepatitis
#PediatricHepatology
#ProtectEveryChild

Sample Posts – Facebook

On World Hepatitis Day 2026, FISPGHAN joins the global call to break down the barriers that prevent children and families from accessing hepatitis prevention, testing, treatment and care.

Viral hepatitis can affect children from birth through adolescence. Timely hepatitis B vaccination, maternal screening, prevention of mother-to-child transmission, safe healthcare practices and early diagnosis are essential to protect liver health throughout life.

Together, healthcare professionals, families and communities can improve awareness, reduce stigma and help ensure that every child—regardless of where they live—has access to appropriate prevention and care.

Vaccinate. Test. Treat. Protect.

#WorldHepatitisDay #FISPGHAN #ProtectEveryChild

Sample Posts – LinkedIn (Professional Tone)

On World Hepatitis Day 2026, FISPGHAN joins the international health community in calling for stronger action to prevent, diagnose and treat viral hepatitis in children and adolescents.

Effective interventions already exist, including maternal hepatitis B screening, timely neonatal vaccination, prevention of mother-to-child transmission, appropriate testing of children at risk and access to antiviral treatment. However, gaps in awareness, healthcare access and implementation continue to limit their impact.

As a global federation committed to pediatric gastroenterology, hepatology and nutrition, FISPGHAN supports collaboration among healthcare professionals, scientific societies, families and policymakers to ensure that every child can benefit from evidence-based hepatitis prevention and care.

Vaccinate. Test. Treat. Protect.

#WorldHepatitisDay #FISPGHAN #PediatricHepatology

Sample Posts – X (280 charactrers or less)

On World Hepatitis Day 2026, FISPGHAN calls for equitable access to vaccination, testing, treatment and care for every child. Vaccinate. Test. Treat. Protect.
#WorldHepatitisDay #FISPGHAN #ProtectEveryChild

Sample Posts – Facebook/Instagram

On 28 July, FISPGHAN joins the global community in observing World Hepatitis Day 2026.

Under the theme “Hepatitis: Let’s Break It Down,” this campaign calls on healthcare professionals, families, communities and decision-makers to remove the barriers that limit access to vaccination, testing, treatment and long-term care.

Viral hepatitis can affect children from birth through adolescence, often without noticeable symptoms. Prevention, early diagnosis and appropriate treatment can protect liver health and prevent serious complications later in life.

Together, we can break down misinformation, stigma and inequalities in care.

Vaccinate. Test. Treat. Protect.

#WorldHepatitisDay #FISPGHAN #ProtectEveryChild

Official Hashtags

#WorldHepatitisDay
#HepatitisLetsBreakItDown
#FISPGHAN
#ViralHepatitis
#PediatricHepatology
#ProtectEveryChild

Episode 7 of FISPGHAN Expert Insights, featuring Professor Yen-Hsuan Ni from National Taiwan University in an important discussion on hepatitis B infection in children. In this episode, he explains why hepatitis B acquired in infancy remains a major global health concern, highlights the critical importance of vaccination within 24 hours after birth, and explores the public health and treatment challenges that still affect pediatric care worldwide. Moderated by Dr. Songpon Getsuwan from Ramathibodi Hospital, Bangkok. Produced by Dr. Carlos Timossi.

Episode 8 of FISPGHAN Expert Insights, featuring Professor Giuseppe Indolfi from Meyer Children’s Hospital and the University of Florence in an important discussion on hepatitis C infection in children. In this episode, he explains why pediatric hepatitis C remains a global health concern despite highly effective therapies, reviews current screening strategies for at-risk children, and highlights how direct-acting antivirals have transformed treatment through safer, shorter, and highly successful care. Moderated by Dr. Songpon Getsuwan. Coordination by Dr. Carlos Timossi.